Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 11:12:627493.
doi: 10.3389/fneur.2021.627493. eCollection 2021.

Impact of National Lockdown on the Hyperacute Stroke Care and Rapid Transient Ischaemic Attack Outpatient Service in a Comprehensive Tertiary Stroke Centre During the COVID-19 Pandemic

Affiliations

Impact of National Lockdown on the Hyperacute Stroke Care and Rapid Transient Ischaemic Attack Outpatient Service in a Comprehensive Tertiary Stroke Centre During the COVID-19 Pandemic

Lucio D'Anna et al. Front Neurol. .

Abstract

Background: The COVID-19 pandemic is having major implications for stroke services worldwide. We aimed to study the impact of the national lockdown period during the COVID-19 outbreak on stroke and transient ischemic attack (TIA) care in London, UK. Methods: We retrospectively analyzed data from a quality improvement registry of consecutive patients presenting with acute ischemic stroke and TIA to the Stroke Department, Imperial College Health Care Trust London during the national lockdown period (between March 23rd and 30th June 2020). As controls, we evaluated the clinical reports and stroke quality metrics of patients presenting with stroke or TIA in the same period of 2019. Results: Between March 23rd and 30th June 2020, we documented a fall in the number of stroke admissions by 31.33% and of TIA outpatient referrals by 24.44% compared to the same period in 2019. During the lockdown, we observed a significant increase in symptom onset-to-door time in patients presenting with stroke (median = 240 vs. 160 min, p = 0.020) and TIA (median = 3 vs. 0 days, p = 0.002) and a significant reduction in the total number of patients thrombolysed [27 (11.49%) vs. 46 (16.25%, p = 0.030)]. Patients in the 2020 cohort presented with a lower median pre-stroke mRS (p = 0.015), but an increased NIHSS (p = 0.002). We registered a marked decrease in mimic diagnoses compared to the same period of 2019. Statistically significant differences were found between the COVID and pre-COVID cohorts in the time from onset to door (median 99 vs. 88 min, p = 0.026) and from onset to needle (median 148 vs. 126 min, p = 0.036) for thrombolysis whilst we did not observe any significant delay to reperfusion therapies (door-to-needle and door-to-groin puncture time). Conclusions: National lockdown in the UK due to the COVID-19 pandemic was associated with a significant decrease in acute stroke admission and TIA evaluations at our stroke center. Moreover, a lower proportion of acute stroke patients in the pandemic cohort benefited from reperfusion therapy. Further research is needed to evaluate the long-term effects of the pandemic on stroke care.

Keywords: COVID-19; lock down; stroke; stroke care; thrombolisis; transient ischaemic attack.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Map of the catchment area for mechanical thrombectomy of the Charing Cross Hospital and referring centers. CXH, Charing Cross Hospital.
Figure 2
Figure 2
Numbers of patients with diagnosis of intracranial hemorrhage, transient ischaemic attack, stroke mimic and ischaemic stroke between March 23rd and 30th June 2020 and between March 23 and 30 June 2019.
Figure 3
Figure 3
Process measure comparison for intravenous thrombolysis between stroke patients admitted between March 23 and 30 June 2020 and between March 23 and 30 June 2019.

Similar articles

Cited by

References

    1. Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, et al. . First cases of coronavirus disease 2019 (COVID-19) in France: Surveillance, investigations and control measures. Euro Surveill. (2020) 25:2000094. 10.2807/1560-7917.ES.2020.25.6.2000094 - DOI - PMC - PubMed
    1. Lillie PJ, Samson A, Li A, Adams K, Capstick R, Barlow GD, et al. . Novel coronavirus disease (Covid-19): the first two patients in the UK with person to person transmission. J Infect. (2020) 80:578–606. 10.1016/j.jinf.2020.02.020 - DOI - PMC - PubMed
    1. Bersano A, Pantoni L. Impact of the SARS-CoV-2 pandemic on stroke care: a warning message. Eur J Neurol. (2020) 27:1781–2. 10.1111/ene.14394 - DOI - PMC - PubMed
    1. Bersano A, Kraemer M, Touzé E, Weber R, Alamowitch S, Sibon I, et al. . Stroke care during the COVID-19 pandemic: experience from three large European countries. Eur J Neurol. (2020) 27:1794–1800. 10.1111/ene.14375 - DOI - PMC - PubMed
    1. Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, et al. . Impact of the COVID-19 epidemic on stroke care and potential solutions. Stroke. (2020) 51:1996–2001. 10.1161/STROKEAHA.120.030225 - DOI - PMC - PubMed